What is ImmunityBio, Inc.'s quick ratio?

ImmunityBio, Inc. (IBRX) reported quick ratio of 6.4× in Q1 2026.

How has ImmunityBio, Inc.'s quick ratio changed year-over-year?

ImmunityBio, Inc.'s quick ratio increased by 212.1% year-over-year, from 2× to 6.4×.

What is the long-term trend for ImmunityBio, Inc.'s quick ratio?

Over 5 years (2020 to 2025), ImmunityBio, Inc.'s quick ratio has grown at a 24.4% compound annual growth rate (CAGR), from 1.6× to 4.9×.

What does quick ratio mean?

Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.

ImmunityBio, Inc. IBRX Quick ratio

Quick ratio at other companies

Bristol-Myers SquibbBMY

1.3×+0.1×

Johnson & JohnsonJNJ

0.8×-0.3×

Merck & Co.MRK

1.1×-0.2×

Gilead SciencesGILD

1.7×+0.5×

Immunovant, Inc.IMVT

9.1×-2.1×

Kymera TherapeuticsKYMR

10.8×+2.3×

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Calculated from ImmunityBio, Inc.’s reported figures.

quick assets/total current liabilities=6.4×

Based on the most recent quarter.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s quick ratio?: ImmunityBio, Inc. (IBRX) reported quick ratio of 6.4× in Q1 2026.
How has ImmunityBio, Inc.'s quick ratio changed year-over-year?: ImmunityBio, Inc.'s quick ratio increased by 212.1% year-over-year, from 2× to 6.4×.
What is the long-term trend for ImmunityBio, Inc.'s quick ratio?: Over 5 years (2020 to 2025), ImmunityBio, Inc.'s quick ratio has grown at a 24.4% compound annual growth rate (CAGR), from 1.6× to 4.9×.
What does quick ratio mean?: Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.